Angiogenesis in cancer, vascular, rheumatoid and other disease

[1]  L. Ellis,et al.  The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.

[2]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[3]  Joan W. Miller,et al.  Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. , 1994, American journal of ophthalmology.

[4]  Erwin G. Van Meir,et al.  Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells , 1994, Nature Genetics.

[5]  K. Dameron,et al.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.

[6]  Joan W. Miller,et al.  Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.

[7]  S. Gammal,et al.  The elongation of psoriatic capillaries, the result of epidermal hyperplasia, not of angiogenesis , 1994 .

[8]  P. Black,et al.  Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours , 1994, The Lancet.

[9]  B. Teicher,et al.  Potentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agents , 1994, International journal of cancer.

[10]  J. Mulliken,et al.  Cellular markers that distinguish the phases of hemangioma during infancy and childhood. , 1994, The Journal of clinical investigation.

[11]  R. Kerbel,et al.  Progressive loss of sensitivity to endothelium‐derived growth inhibitors expressed by human melanoma cells during disease progression , 1994, Journal of cellular physiology.

[12]  R. D'Amato,et al.  Thalidomide is an inhibitor of angiogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  V. Dixit,et al.  Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. , 1994, The American journal of pathology.

[14]  J. Richie,et al.  Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. , 1994, Journal of the National Cancer Institute.

[15]  J. Folkman.  Angiogenesis and breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  E. Brogi,et al.  Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.

[17]  S. Koscielny,et al.  Re: Local recurrences following mastectomy: support for the concept of tumor dormancy. , 1994, Journal of the National Cancer Institute.

[18]  C. Cordon-Cardo,et al.  Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. , 1993, Journal of the National Cancer Institute.

[19]  W Blumenfeld,et al.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.

[20]  A. Ullrich,et al.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis , 1993, Cell.

[21]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[22]  H. Seigler,et al.  Relationship between disease-free interval and survival in patients with recurrent melanoma. , 1992, Archives of surgery.

[23]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[24]  Georg Breier,et al.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.

[25]  G. Nicolson,et al.  Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. , 1992, British Journal of Cancer.

[26]  H. Phillips,et al.  Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. , 1992, Endocrinology.

[27]  J. Mulliken,et al.  Interferon alfa‐2a therapy for life‐threatening hemangiomas of infancy , 1992, The New England journal of medicine.

[28]  E. Brahn,et al.  Angiogenesis inhibition suppresses collagen arthritis , 1992, The Journal of experimental medicine.

[29]  S. Killilea,et al.  Angiogenesis in the female reproductive system , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  S. Szabó,et al.  Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. , 1991, Annals of surgery.

[31]  D. Hanahan,et al.  Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma , 1991, Cell.

[32]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[33]  R. Kerbel,et al.  Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti‐cancer therapeutic agents , 1991, BioEssays : news and reviews in molecular, cellular and developmental biology.

[34]  N. Bouck.  Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. , 1990, Cancer cells.

[35]  B. Zetter,et al.  The cellular basis of site-specific tumor metastasis. , 1990, The New England journal of medicine.

[36]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[37]  T J Poole,et al.  Vasculogenesis and angiogenesis: two distinct morphogenetic mechanisms establish embryonic vascular pattern. , 1989, The Journal of experimental zoology.

[38]  G. S. Greenwald,et al.  Temporal and topographic changes in DNA synthesis after induced follicular atresia. , 1989, Biology of reproduction.

[39]  N. Ferrara,et al.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.

[40]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[41]  Peter J. Polverini,et al.  Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene , 1989, Cell.

[42]  M. Kripke.  Immunoregulation of Carcinogenesis: Past, Present, and Future1 , 1988 .

[43]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[44]  W. Risau,et al.  Production of a heparin-binding angiogenesis factor by the embryonic kidney , 1986, The Journal of cell biology.

[45]  J. L. Bethune,et al.  Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. , 1985, Biochemistry.

[46]  A. Schreiber,et al.  Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. , 1984, Science.

[47]  J. Folkman,et al.  Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. , 1984, Science.

[48]  I. Fidler,et al.  The pathogenesis of cancer metastasis , 1980, Nature.

[49]  C. Wirth.  Metastatic bone cancer. , 1979, Current problems in cancer.

[50]  S. Szabó.  Duodenal ulcer disease. Animal model: cysteamine-induced acute and chronic duodenal ulcer in the rat. , 1978, The American journal of pathology.

[51]  J. Yuhas,et al.  Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread. , 1974, Cancer research.

[52]  L. Liotta,et al.  Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. , 1974, Cancer research.

[53]  M. Morrow,et al.  Risk factors and the prevention of breast cancer with tamoxifen. , 1993, Cancer surveys.

[54]  D. Redmer,et al.  Production of mitogenic factors by cell types of bovine large estrogen-active and estrogen-inactive follicles. , 1991, Journal of animal science.

[55]  R T Prehn,et al.  The inhibition of tumor growth by tumor mass. , 1991, Cancer research.